Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02234479 · ClinicalTrials.gov registry record · NA
MediHoney for Radiation Dermatitis
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT02234479 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 34 participants.
The verdict
NCT02234479, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The aim of this study is to compare the effects of Medihoney and Hydrophor on radiation dermatitis reactions in a group of women undergoing radiation therapy for breast cancer. It is hoped that the outcome of this pilot study will provide evidence supporting the use of Medihoney in preventing and treating radiation dermatitis as well as sufficient preliminary data to expand this study to larger, federally funded research (R01) looking at the beneficial aspects of Medihoney across a spectrum of radiation dermatitis and mucositis in several disease settings.
Interventions
- BIOLOGICAL Hydrophor (Group A)
- BIOLOGICAL MediHoney (Group B)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2014-06 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02234479
The ClinicalTrials.gov registry entry for NCT02234479 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydrophor (Group A) is the first listed.
NCT02234479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02234479 about?
NCT02234479 is a clinical study titled "MediHoney for Radiation Dermatitis". The aim of this study is to compare the effects of Medihoney and Hydrophor on radiation dermatitis reactions in a group of women undergoing radiation therapy for breast cancer. It is hoped that the outcome of this pilot study will provide evidence supporting the use of Medihoney in preventing and tr...
What is the current status of trial NCT02234479?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2014-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02234479?
The interventions under investigation include: Hydrophor (Group A) (BIOLOGICAL), MediHoney (Group B) (BIOLOGICAL).
Who is sponsoring clinical trial NCT02234479?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.